UCB SA (UCB) short interest & options flow
ENXTBRUCB shares closed at €259.10 on Thursday, up 21.6% on the day and 25.8% over the week, a move that dwarfs the median 3.4% gain among its closest pharma peers ahead of Monday's earnings release. The most striking feature of that rally is what the lending market is not saying. Short interest in UCB is negligible: availability in the borrow pool amounts to roughly 5,828% of shares…
UCB cost to borrow surges to 1.94%, up 219% in one week as short-covering demand intensifies on the Brussels-listed pharma name.
- Market cap
- $63.46B
- Next earnings
- 25 Feb 2027
Key data as of 10 Nov 2026

UCB news and analysis
RSSNo long-form analysis yet for UCB. Pulse alerts and the live data picture are available on ORTEX.
Open UCB on ORTEX →Want the live picture for UCB?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for UCB — free to start on ORTEX.
Sign up for free →Open UCB on ORTEX